ABL Bio Inc. (KOSDAQ:298380)
South Korea · Delayed Price · Currency is KRW
194,000
+2,900 (1.52%)
At close: Feb 27, 2026
Revenue by Segment
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|
| Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
|---|
| 33.40B | 65.55B | 67.30B | 5.33B |
Biotechnology (Startups) Growth | -49.04% | -2.61% | 1162.19% | - |
| 33.40B | 65.55B | 67.30B | 5.33B |
| -49.04% | -2.61% | 1162.19% | - |
Revenue by Geography
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|
| Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
|---|
| 300.00M | 2.00B | 2.38B | 483.55M |
| -84.97% | -16.30% | 393.11% | - |
| 33.10B | 63.55B | 62.32B | 4.85B |
| -47.91% | 1.98% | 1185.24% | - |
| - | - | 2.60B | - |
| 33.40B | 65.55B | 67.30B | 5.33B |
| -49.04% | -2.61% | 1162.19% | - |
Source: S&P Global Market Intelligence.